Escolar Documentos
Profissional Documentos
Cultura Documentos
a. Department of Materials Science and Engineering, School of Engineering, Shiraz University, Shiraz, Iran
b. Department of Dental Materials and Biomaterial Research center, Shiraz University of Medical Sciences, Shiraz,
Iran
Cite this article as: Abbasi Z, Bahrololoom ME, Shariat MH, Bagheri R. Bioactive Glasses in Dentistry: A Review. J Dent
Biomater, 2015;2(1):1-9.
1. Introduction of bioactive glass bioactivity increases with the amount of CaO in the
Bioactive glasses are a group of biomaterials which composition, because the dissolution of the calcium
are used in the fields of dentistry and orthopedics. ion from the glass plays an important role in formation
Forty five years ago, these glasses modified the func- of the chemical bond [5].
tions and capabilities of biomaterials from bioinert to Results of in vivo implantation of bioactive glasses
bioactive by stimulating a strong response after im- show that these materials produce no toxicity, no in-
planting in the human body (e.g. osteoproductivity) flammation, and no foreign-body response [6]. In fact,
[1]. A material can be classified as bioactive if the these glasses bond with the bone through formation of
above-mentioned biological response results in for- a hydroxyapatite (HAp) layer. The same HAp layer is
mation of a strong chemical bond between the im- formed on the surfaces of these materials after soaking
planted material and a soft or hard tissue [2]. Certain in the simulated body fluid (SBF) which has ion con-
compositions of the silicate-based glasses, with calci- centrations similar to the human blood plasma [7].
um and phosphorus in proportions identical to those of Hench at the University of Florida introduced the
natural bone, can form such a strong bond without an first bioactive glass in 1969 [3]. Those days, the avail-
intervening fibrous layer [3]. When the glass contains able implant materials (metals and polymers) designed
more than 60% SiO2, bonding to tissues is no longer to be bioinert had a problem; they initiated fibrous
observed [4]. On the other hand, it is expected that encapsulation after implantation, rather than forming a
stable bond with the tissues. Hench began his work to In 1980, Hench showed that the in vivo formation
overcome this problem by finding a material that of the HAp layer can be reproduced in Tris buffer
could bond to the bone and survive the harsh envi- solution at pH 7.4. Later, Kokubo and Hench
ronment of the human body. He tried making a de- independently confirmed that apatite can form on the
gradable glass in the Na2O-CaO-SiO2-P2O5 system ®
surface of Bioglass in SBF. In 1991, it was suggested
with high calcium content [3]. He discovered such that a sim- ulated body fluid (SBF) which has the ion
glass with the composition of 46.1 mol.% SiO2, 24.4 concentra- tions equal to human blood plasma can
mol.% Na2O, 26.9 mol.% CaO and 2.6 mol.% P2O5 reproduce HAp formation [3]. Thin film X-ray
®
(later termed 45S5 and Bioglass ) which formed a diffraction (TF-XRD), Fourier transform infrared
bond with the bone so tightly that it could not be re- spectroscopy (FTIR), scan- ning electron microscopy
moved without breaking the bone. In fact, this glass (SEM) and transmission elec- tron microscopy (TEM)
bonds with bone rapidly and stimulates bone growth were used to confirm the simi-
away from the bone-implant interface. This bone larity of the composition and structure of HAp formed
bonding is the result of HAp layer formation on the in SBF to the bone mineral [12]. Hence, immersion in
surface of the glass, following initial glass dissolution SBF can be used for in vivo bone bioactivity prediction
[2]. This discovery was the introduction of the field of before animal testing; this reduces the number of ani-
bioactive ceramics and the beginning of the formation mals used and the duration of experiments and, there-
of many new materials such as synthetic hydroxyap- fore, increases the possibility of the development of
atite (HAp) and other calcium phosphates [8]. All new types of bioactive materials [3].
glasses, glass-ceramics and ceramics that are used as SBF is a solution that simulates human blood
implant materials are called “bioceramics” but plasma with ion compositions similar to human blood,
®
“Bioglass ” is referred to as the original 45S5 compo- but without any proteins, hormones, glucose, or vita-
sition and should not be used as a general term for mins [13]. During immersion in SBF, different pro-
bioactive glasses [9]. Table 1 presents the composi- cesses occur simultaneously which result in structural
tions of the bioactive glasses mentioned in this review. and chemical changes to the surface of the material.
These processes are leaching, degradation, and precip-
Table 1: Compositions of three types of bioactive glass- itation [14]. In the leaching process, through the ex-
es. + +
change of the cations H and H3O , metal ions like
Name Composition + 2+
Na and Ca are released and the pH at the interface
46.1 mol.% SiO2, 24.4 mol.% Na2O, 26.9
45S5 (Bioglass®) mol.% CaO and 2.6 mol.% P2O5 increases up to 7.4. In parallel, hydroxyl ions locally
break the silica-oxygen bonding. Then, silicon as silic-
58S (Sol-gel 60 mol.% SiO2, 36 mol.% CaO and 4 mol.% ic acid, Si(OH)4, is released into the solution. The hy-
derived) P2O5 drated silicic acid on the surface is surrounded by at
S53P4
53 mol.% SiO2, 23 mol.% Na2O, 20 mol.%
CaO and 4 mol.% P2O5
least one hydroxy group; subsequently, a silicic acid
gel layer forms. Simultaneously, the glass releases
calcium and phosphorus and an amorphous calcium
2. The mechanism of HAp layer formation on bio- phosphate-rich phase is formed on the surface. The
active glasses CaP phase then crystallizes into a hydroxyapatite
Hydroxyapatite is similar to the bone mineral and can (HAp) structure [14].
interact with collagen fibrils of damaged bone to bond
with it. Protein adsorption, incorporation of collagen 3. Processing methods
fibrils, attachment of bone progenitor cells, cell differ- For years, conventional glass technology has been
entiation, the excretion of bone extracellular matrix used to produce bioactive glasses. Mixture of oxides
and its mineralization are involved in the formation of or carbonates grains, as the glass components, are
HAp layer-bone bond. Osteogenesis, due to the disso- melted in a platinum crucible and homogenized at
lution products of the glass on osteoprogenitor cells, high temperatures up to 1250-1400°C. Then, to pro-
stimulates new bone growth [10]. duce a bulk implant, the molten glass is cast into steel
The mechanism of HAp layer formation on bioac- or graphite mold. For the required tolerance, a final
tive glasses has been widely studied in vitro and in grind and polish is often necessary. Sometimes, bioac-
vivo. This process involves different stages; calcium tive glass powders are required for some clinical ap-
ions dissolve from the bioactive glass into the body plications such as treatment of periodontal lesions. In
fluid while a silica-rich interlayer forms on the glass conventional glass technology, the molten glass is
surfaces. The nucleation of HAp is now possible be- poured into water or other liquid medium to produce
cause the surrounding fluid is supersaturated with re- small fragments. To achieve powders with specific
spect to HAp due to the dissolution of the calcium size ranges for periodontal treatment, subsequent
ions. In addition, silica-rich interlayer dissolves a con- grinding is necessary [4].
siderable amount of silicate ion and provides favorable Producing bioactive glasses by conventional glass
sites for the nucleation. The process of nucleation and technology has several disadvantages as listed below
growth of the HAp layer continues by the reactions of (A-D). A: Very high purity is necessary for optimal
the calcium, phosphate, and hydroxide ions. It is pos- bioactivity which is difficult to maintain in this meth-
sible that carbonate or fluoride anions incorporate in od due to the high temperatures of processing, the low
the reactions, as well [3,9,11].